Cross Country Healthcare (CCRN) Downgraded by BidaskClub to “Sell”

BidaskClub cut shares of Cross Country Healthcare (NASDAQ:CCRN) from a hold rating to a sell rating in a research note issued to investors on Thursday, December 21st.

A number of other brokerages have also recently commented on CCRN. TheStreet cut shares of Cross Country Healthcare from a b- rating to a c+ rating in a research note on Friday, November 3rd. Cantor Fitzgerald reaffirmed a buy rating and set a $18.00 price target on shares of Cross Country Healthcare in a research note on Wednesday, November 1st. Credit Suisse Group assumed coverage on shares of Cross Country Healthcare in a research note on Tuesday, November 7th. They set a neutral rating and a $13.00 price target for the company. Zacks Investment Research cut shares of Cross Country Healthcare from a hold rating to a sell rating in a research note on Monday, October 9th. Finally, BMO Capital Markets dropped their price target on shares of Cross Country Healthcare from $15.00 to $14.00 and set an outperform rating for the company in a research note on Monday, November 6th. Four investment analysts have rated the stock with a hold rating and five have given a buy rating to the company. The company presently has a consensus rating of Buy and a consensus target price of $15.31.

Cross Country Healthcare (NASDAQ:CCRN) opened at $12.92 on Thursday. The firm has a market cap of $463.67, a price-to-earnings ratio of 19.86, a P/E/G ratio of 1.65 and a beta of 0.75. Cross Country Healthcare has a 52 week low of $11.07 and a 52 week high of $16.38. The company has a debt-to-equity ratio of 0.46, a quick ratio of 2.14 and a current ratio of 2.14.

Cross Country Healthcare (NASDAQ:CCRN) last posted its earnings results on Wednesday, November 1st. The business services provider reported $0.23 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.18 by $0.05. Cross Country Healthcare had a net margin of 0.19% and a return on equity of 11.69%. The company had revenue of $228.50 million during the quarter, compared to analysts’ expectations of $228.97 million. During the same period last year, the company posted $0.24 earnings per share. Cross Country Healthcare’s quarterly revenue was up 6.3% on a year-over-year basis. equities analysts predict that Cross Country Healthcare will post 0.64 EPS for the current fiscal year.

In other news, General Counsel Susan E. Ball sold 25,000 shares of the business’s stock in a transaction dated Friday, December 8th. The shares were sold at an average price of $14.19, for a total value of $354,750.00. Following the completion of the sale, the general counsel now owns 126,921 shares in the company, valued at approximately $1,801,008.99. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, Director Thomas C. Dircks acquired 10,000 shares of Cross Country Healthcare stock in a transaction that occurred on Monday, November 6th. The shares were purchased at an average price of $11.77 per share, with a total value of $117,700.00. Following the purchase, the director now owns 104,571 shares in the company, valued at $1,230,800.67. The disclosure for this purchase can be found here. Insiders own 3.90% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. BNP Paribas Arbitrage SA raised its stake in shares of Cross Country Healthcare by 57.7% during the 2nd quarter. BNP Paribas Arbitrage SA now owns 9,998 shares of the business services provider’s stock worth $129,000 after acquiring an additional 3,660 shares in the last quarter. FDx Advisors Inc. bought a new position in shares of Cross Country Healthcare during the 3rd quarter worth approximately $146,000. Strs Ohio raised its stake in shares of Cross Country Healthcare by 69.5% during the 3rd quarter. Strs Ohio now owns 16,100 shares of the business services provider’s stock worth $229,000 after acquiring an additional 6,600 shares in the last quarter. Voya Investment Management LLC raised its stake in shares of Cross Country Healthcare by 16.9% during the 2nd quarter. Voya Investment Management LLC now owns 18,329 shares of the business services provider’s stock worth $237,000 after acquiring an additional 2,646 shares in the last quarter. Finally, Los Angeles Capital Management & Equity Research Inc. bought a new position in shares of Cross Country Healthcare during the 2nd quarter worth approximately $246,000. Hedge funds and other institutional investors own 92.08% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Cross Country Healthcare (CCRN) Downgraded by BidaskClub to “Sell”” was first posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another website, it was stolen and reposted in violation of U.S. and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dispatchtribunal.com/2018/01/14/cross-country-healthcare-ccrn-lowered-to-sell-at-bidaskclub.html.

Cross Country Healthcare Company Profile

Cross Country Healthcare, Inc is engaged in providing healthcare recruiting, staffing, recruiting and workforce solutions. The Company operates in three segments: Nurse and Allied Staffing, Physician Staffing and Other Human Capital Management Services. The Nurse and Allied Staffing segment provides traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch-based local nurses and allied staffing.

Analyst Recommendations for Cross Country Healthcare (NASDAQ:CCRN)

Receive News & Ratings for Cross Country Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cross Country Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply